Skip to main content
SpringerLink
Log in

Wirkungsweisen und klinischer Einsatz von Antigestagenen

  • Conference paper
Gynäkologie und Geburtshilfe 1992

  • 7 Accesses

Zusammenfassung

Seit ihrer Entdeckung im Jahre 1980 finden 19-nor Testeron derivate mit einer Aminophenylgruppe In Position C11 und einer mehr oder weniger langkettigen Substitution in Position C17 zunehmendes Interesse in Forschung und Klinik. Die Summe der Publikationen steigt exponentiell. Derzeit sind ca 800 Originalarbeiten und Übersichtartikel Veröffentlich. Das Interesse ist auf zwei Substabzen focusiert: Mifepriston und Onapriston. Diese Steroide haben einige Gemeinsamkeiten, unterscheiden sich jedoch deutlich in wesentlichen Punkten hinsichtlich ihre Bioverfügbarkeit, ihres Wirkspektrum und ihrer Steriodrezeptorenbeeinflussung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Van Look, P.F.A., Bygdeman, M., 1989 Antiprogestational steroids: a new dimendion in human fertility. Reviews of reproductive Biology(S.Milligan), pp 2–44, Oxford Univ. Press

    Google Scholar 

  2. Benhamou, B. et al. 1989 A Single amino acid that determinates the sensivity of progesteron receptors to RU 486 Science 245, 206–209

    Google Scholar 

  3. Baulieu, E.E. 1989 Contragestion and other clinical applications of RU 486, antiprogesterone at the receptor Science 245, 1351–1357

    Article  PubMed  CAS  Google Scholar 

  4. Klein-Hitpass, L. et al. 1991 Two types of antiprogestines identified by their differential action in transcriptionally active extracsts from T47D cells Nuclein Acid Research 19, 1227–1234

    Article  CAS  Google Scholar 

  5. Wolf, J.P. et al. 1989 Contraceptive potential of RU 486 by ovulation inhibition: II; II. Suppresion of pituitary gonadotropin secretion in vitro Contraception 40, 185–193

    CAS  Google Scholar 

  6. Ortmann, O. et al. 1989 Inhibitoty effects of the antiprogestin, RU 486, on progesterone actions and luteinizing hormone secretion in pituitary gonadotrophs J. Steroid Biochem. 32, 291–297

    Article  PubMed  CAS  Google Scholar 

  7. Uilenbroek, J.T. 1991 Hormone concentrations and ovualtory response in rats treated with antiprogestagenes j.Endocrinol. 129, 423–429

    Article  PubMed  CAS  Google Scholar 

  8. Koering, M.J. et al., 1986 Morphologie response of endometrium to a progesterone receptor antagonist, RU 486, in monkey Ferti.Steril 45, 280–287

    CAS  Google Scholar 

  9. Shoupe, D. et al., 1987 Effect of the antiprogesterone Ru 486 in normal women. I. Single dose administration in the midluteal phase Am. j. Obstet. Gynecol. 157, 1415–1420

    PubMed  CAS  Google Scholar 

  10. Shoupe, D. et al. 1987 Effect of the antiprogesterone Ru 486 in normal women; II. Administration in the late luteal phase Am. J. Obstet. Gynecol. 157, 1421–1426

    PubMed  CAS  Google Scholar 

  11. Ledger, W.L. et al. 1992 Inhibition of ovulation by low dose mifeprestone (RU 486) Hum Reprod. 7, 945–950

    PubMed  CAS  Google Scholar 

  12. Batista, M.C. et al. 1992 Evidence for a critical role of progesterone in the regulation of the mydcycle gonadotropin surgeans ovulation JCEM 74, 565–570

    PubMed  CAS  Google Scholar 

  13. Schmidt, RJ. et al. 1991 Lack of effect of induced menses on symptomes in women with premenstrual Syndrome N. Engl. J. Med. 324, 1174–1179

    Article  PubMed  CAS  Google Scholar 

  14. Baulieu, E.E. 1989 Contragestion with RU 486: a new approach to postovulatory fertility control Acta Obstet. Gynecol. Scand. Suppl. 149, 5–8

    CAS  Google Scholar 

  15. Swahn, M.L. et al. 1991 Contraception with mifepristone Lancet 338, 942–943

    Article  PubMed  CAS  Google Scholar 

  16. WHO 1991 Pregnancy termination with mifepristone and gemeprost: a multicentre comparison between repeated doses and a Single dose of mifepristone Fertil. Steril 56, 32–40

    Google Scholar 

  17. Delay, M. et al. 1992 Arret cardiocirculatoire apres administration de l’association mifepristone (MifgyneR) sulprostone (NaladorR) pour interruption de grossesse. Role evoque du spasma coronaire Arch. Mal. Coeur. Vaiss. 85, 105–107

    PubMed  CAS  Google Scholar 

  18. Norman, J.E. et al. 1991 Uterine contractility and induction of abortion in early pregnancy by mosoprristol and mifepristone Lancet 338, 122–1236

    Article  Google Scholar 

  19. Cingotti, M. et al.. 1990 Traitement de la grossesse extra uterine par le RU 486. A propos d’un cas. Rev. Fr. Gynecol. Obstet. 85, 611–613

    Google Scholar 

  20. Kelly, R.W. et al. 1992 Choriodecidual Produktion of interleukin -8 and mechanism of parturition Lancet 339, 776–777

    Article  PubMed  CAS  Google Scholar 

  21. Urquhart, D.R., Templeton, A.A. 1990 The use of mifepristone prior to Prostaglandine induced midtrimester abortion Hum. Reprod. 5, 883–886

    PubMed  CAS  Google Scholar 

  22. Chwalisz, K. et al. 1991 The progesteerone antagonist onapristone increases the effectiveness of oxitocin to produce delivery without changing the myometrial oxytocin receptor Am. J. Obstet. Gynecol. 165, 1760–1770

    PubMed  CAS  Google Scholar 

  23. Hill, N.C. et al. 1991 Transplacental passage of mifepristone and its influence on maternal and fetal steriod cencentrations in second trimester of pregnancy Hum. Reprod. 6, 458–462

    PubMed  CAS  Google Scholar 

  24. Lim, B.H. et al. 1990 Normal development after exposure to mifepristone in early pregnancy Lancet 336, 257–258

    Article  PubMed  CAS  Google Scholar 

  25. Pons, J.C., Papiernik, E. Mifepristone teratogenicity Lancet 338, 1332–1333

    Google Scholar 

  26. Wolf, J.P. et al. 1989 Noncopetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrated monkeys Fertil. Steril. 52, 1055–1060

    PubMed  CAS  Google Scholar 

  27. Neulen, J. et al. 1990 RU 486 (Mifepristone): induction of dose dependent elevation of estradiol receptor in endometrium from ovariectomized monkeys JCEM 71, 1074–1075

    PubMed  CAS  Google Scholar 

  28. Murphy, A.A. 1992 Progesterone antagonists in the treatment of endoemetriosis andleiomy- omata uteri Abstract Terra Symposia III, Mohonk, NY

    Google Scholar 

  29. Kettel, L.M. et al. 1991 Endocrine response to long term administration of the antiproge- sterone RU 486 in patients with pelvic endoemtriosis Fertil. Steril 56, 402–407

    PubMed  CAS  Google Scholar 

  30. Schneider, M.R. et al. 1992 The tumor-inhibiting potential of the progesterone anagonist onapristone in the mammary carcioma T61 in nude mice J. Cancer Res. Clin. Oncol. 118, 187–189

    Article  PubMed  CAS  Google Scholar 

  31. Klijn, J.G. et al. 1989 Antiprogestins, anew form of ondocrine therapy for human breast cancer Cancer Res. 49, 2851–2856

    PubMed  CAS  Google Scholar 

  32. Poulin, R. et al. 1989 Androgen and glucocortocoid receptor-mediated inhibition of cell proliferation by mydroxyprogesterone acetate in ZR-75–1 human breast cancer cells Breast cancer Res. Treat. 13, 161–172

    Article  PubMed  CAS  Google Scholar 

  33. Grunberg, et al. 1991 Treatment of unrecestable menigiomas with the antiprogesterone agent mifepristone J. Nuerosurg. 74, 861–866

    Article  CAS  Google Scholar 

  34. Bertagna, X. 1989 L’action antiglucocortocoide du RU 486. Ann. Endocrinol. (Paris) 50, 208–217

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Frauenklinik, Freiburg im Breisgau, Deutschland

    Dr. med. Joseph Neulen

Authors
  1. Dr. med. Joseph Neulen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Frauenklinik, Universität Bonn, Sigmund-Freud-Straße 25, D - 53105, Bonn, Deutschland

    Dieter Krebs

  2. Frauenklinik, Klinikum St. Marien, Mariahilfbergweg 7, D - 92224, Amberg, Deutschland

    Dietrich Berg

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Neulen, J. (1993). Wirkungsweisen und klinischer Einsatz von Antigestagenen. In: Krebs, D., Berg, D. (eds) Gynäkologie und Geburtshilfe 1992. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77857-5_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77857-5_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77858-2

  • Online ISBN: 978-3-642-77857-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation